title: Flecainide-induced Increase in QRS Duration and Proarrhythmia during Exercise.
abstract: In patients taking flecainide, exercise-induced arrhythmias are believed to be related to QRS widening at rest and during exercise. Our aim was to determine, retrospectively, predictive factors of flecainide-induced (a) QRS widening at rest and during exercise, and (b) proarrhythmia (PA) during exercise. Flecainide was administered to 119 patients for atrial and/or ventricular arrhythmias who performed a maximal treadmill test. A total of 63 patients had a normal heart (defined by the absence of structural heart disease and an ejection fraction ≥ 55% by echocardiography and/or cardiac catheterisation), 26 had coronaropathy, 18 valvulopathy and 3 had both, and 7 had dilated and 2 hypertrophic cardiomyopathy. The mean dosage of flecainide was 190 or 200 ± 10 mg/day. Previous myocardial infarction (MI) was a predictive variable of flecainide-induced QRS widening at rest (p = 0.04). During exercise, the risk factors of QRS widening were previous MI (p = 0.008), angina without previous MI (p = 0.009), structural heart disease (p = 0.001) and a bundle branch block at rest (p = 0.01). PA on exercise occurred in 7 patients. Structural heart disease (p = 0.04) and an impaired left ventricular ejection fraction (LVEF) [p = 0.02] were predictive variables of PA. All patients with left ventricular dysfunction and PA had a QRS widening with flecainide at rest ≥ 25%. The risk factors of QRS widening at rest and during exercise with flecainide were distinct from those of PA on exercise. In patients with an impaired LVEF, a flecainide-induced QRS widening of 25% at rest was the threshold value beyond which there was a high risk of PA during exercise. This study was retrospective and not a double-blind trial, therefore the results need to be corroborated in a prospectively designed trial.
authors: Hôpital Cardiologique du Haut-Leveque, University of Bordeaux II, Pessac, France.
authors: P
authors: P
authors: Bordier
authors: Hôpital Cardiologique du Haut-Leveque, University of Bordeaux II, Pessac, France.
authors: S
authors: S
authors: Garrigue
authors: Hôpital Cardiologique du Haut-Leveque, University of Bordeaux II, Pessac, France.
authors: V
authors: V
authors: Bernard
authors: Hôpital Cardiologique du Haut-Leveque, University of Bordeaux II, Pessac, France.
authors: M
authors: M
authors: Haissaguerre
authors: Hôpital Cardiologique du Haut-Leveque, University of Bordeaux II, Pessac, France.
authors: H
authors: H
authors: Douard
authors: Hôpital Cardiologique du Haut-Leveque, University of Bordeaux II, Pessac, France.
authors: J P
authors: JP
authors: Broustet
authors: Hôpital Cardiologique du Haut-Leveque, University of Bordeaux II, Pessac, France.
authors: J
authors: J
authors: Clementy